Cargando…
Targeting Metabolic Remodeling in Glioblastoma Multiforme
A key aberrant biological difference between tumor cells and normal differentiated cells is altered metabolism, whereby cancer cells acquire a number of stable genetic and epigenetic alterations to retain proliferation, survive under unfavorable microenvironments and invade into surrounding tissues....
Autores principales: | Wolf, Amparo, Agnihotri, Sameer, Guha, Abhijit |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035636/ https://www.ncbi.nlm.nih.gov/pubmed/21317451 http://dx.doi.org/10.18632/oncotarget.190 |
Ejemplares similares
-
Erratum: Targeting Metabolic Remodeling in Glioblastoma Multiforme
por: Wolf, Amparo, et al.
Publicado: (2018) -
Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme
por: Wolf, Amparo, et al.
Publicado: (2011) -
Targeting cellular pathways in glioblastoma multiforme
por: Pearson, Joshua R D, et al.
Publicado: (2017) -
Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014) -
Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017)